2017 has been an interesting year for the FlexAdvantage blog’s coverage of industry news. Government regulations, such as MiFID II and the fixed income trading protocols, were obvious highlights, as were issues concerning data usage, the advent of augmented reality in trading, fragmentation in the options markets, and trends in currency markets. Check out our countdown of the Top 10 FlexAdvantage Blog posts for 2017.
By Ivy Schmerken, Editorial Director North American broker-dealers and asset managers domiciled in the U.S. are watching their European counterparts gear up for compliance with MiFID II. But will MiFID II affect U.S. broker-dealers and asset managers based in the U.S.? Could the massive regulation that requires asset managers to unbundle research payments from executions, …
After more than a decade of debate, regulators are poised to act on a pilot for maker-or-taker pricing, a practice whereby market makers are paid a rebate to add liquidity and are charged a fee to remove liquidity by electronic trading venues. FlexTrade’s Ivy Schmerken investigates.
It’s been an interesting year for the FlexAdvantage blog’s coverage of industry news. From government regulations, such as MiFID II, Last Look, Tick Pilot and Maker Taker, to buy-side involvement in FX and Fixed Income as well as a 20th Anniversary celebration with FlexTrade. Here is our countdown of the Top 10 FlexAdvantage Blog posts for 2016.
Demand for multi-asset trading on the buy side has “renewed” the importance of the execution management system’s role on buy-side trading desks in the battle for screen-based real estate. FlexTrade’s Ivy Schmerken investigates.
With stricter regulations, capital constraints and technology costs impacting the sell side, large brokers are rationing their services and this trend is being felt on equity trading desks. FlexTrade’s Ivy Schmerken investigates.
European regulators are pressing to unbundle research payments from executions. Experts say that a regulatory overhaul driven by MiFID II has the potential to disrupt the global research industry. FlexTrade’s Ivy Schmerken examines further.